InflaRx (IFRX) Gross Margin (2023 - 2025)

InflaRx has disclosed Gross Margin across 3 years of filings, most recently posting 6645.49% for Q4 2025.

• Gross Margin for Q4 2025 came in at 6645.49%, down 66033867.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 8600143.14% (down 859828789.0% YoY), and the FY2025 annual result was 24677.94%, down 2277718.0% from the prior year.
• Gross Margin came in at 6645.49% for Q4 2025 at InflaRx, up from 172.9% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 666984.16% in Q4 2024 to a low of 25781835.34% in Q1 2025.
• The 3-year median for Gross Margin is 511.93% (2024), against an average of 2792457.51%.
• Across the five-year window, Gross Margin jumped 67900778 bps in 2024 and tumbled 2000000000 bps in 2025, its largest moves.
• InflaRx's Gross Margin stood at 12023.62% in 2023, then surged by 5647 bps to 666984.16% in 2024, then slumped by 99 bps to 6645.49% in 2025.
• The last three Gross Margin figures came in at 6645.49% (Q4 2025), 172.9% (Q3 2025), and 5985.37% (Q2 2025), per Business Quant data.